<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82375">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01995448</url>
  </required_header>
  <id_info>
    <org_study_id>I11020 SEPTIFLUX 2</org_study_id>
    <nct_id>NCT01995448</nct_id>
  </id_info>
  <brief_title>Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of Sepsis</brief_title>
  <acronym>SEPTIFLUX2</acronym>
  <official_title>Prognostic Interest of Leucocyte Immunophenotyping Using Multiparameter 8-color Flow Cytometry During the Acute Phase of Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Septic shock is still a major cause of death in ICU. Sepsis diagnosis is linked with many
      clinical, hemodynamic and biological criteria which have a low sensitivity and specificity
      if they are considered separately. The extensive experimental data which have been published
      contrast with the hematological data collected by the physician at patient's bedside
      especially regarding neutrophils and platelets levels. When there is no obvious clinical
      sign, a biological tool reflecting the patient's immune status could be useful to understand
      the physiopathology of Sepsis and to predict the progression of the disease in the patient.
      On the long-term it could also help to define management strategies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>expression of the marker CD10</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expression of CD10 on granulocytes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progession of SOFA score</measure>
    <time_frame>48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of the marker CD16</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expression of CD16 on granulocytes and on monocytes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of the marker CD24</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expression of CD24 on granulocytes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of the marker CD64</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expression of CD64 on granulocytes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of the marker CD14</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expression of CD14 on monocytes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression of the marker CD3</measure>
    <time_frame>28 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Expression of CD3 on T lymphocytes.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">237</enrollment>
  <condition>Sepsis With Acute Organ Dysfunction</condition>
  <arm_group>
    <arm_group_label>SEPSIS Blood test</arm_group_label>
    <description>Patient with two criteria of systemic inflammatory response syndrome and a progressive infection which is clinically or microbiologically documented.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood test</intervention_name>
    <description>Residue of blood further to NFS.</description>
    <arm_group_label>SEPSIS Blood test</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Residue of blood further to NFS.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with two criteria of systemic inflammatory response syndrome and a progressive
        infection which is clinically or microbiologically documented
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient older than 18 years old

          -  Patient with two criteria of systemic inflammatory response syndrome and a
             progressive infection which is clinically or microbiologically documented

        Exclusion Criteria:

          -  Pregnancy,

          -  progressive solid cancer,

          -  HIV infection,

          -  history of blood or inflammatory disease,

          -  long-term immunosuppressive treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno FRANCOIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU LIMOGES</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruno FRANCOIS, MD</last_name>
    <phone>05 55 05 62 54</phone>
    <email>realim@unilim.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean FEUILLARD, MD</last_name>
    <phone>05 55 05 61 80</phone>
    <email>jean.feuillard@unilim.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Bordeaux- Laboratoire Hématologie</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux - Service Réanimation Médicale</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric VARGAS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Frédéric VARGAS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine FLEUREAU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Henri MONDOR - Laboratoire Hématologie</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Henri MONDOR - Service Réanimation</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian BRUN-BUISSON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christian BRUN-BUISSON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Dijon - Laboratoire Hématologie</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Dijon - Service Réanimation Médicale</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre-Emmanuelle CHARLES, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pierre-Emmanuelle CHARLES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Limoges - Service de réanimation polyvalente</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno FRANCOIS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christine VALLEJO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno FRANCOIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Limoges - Laboratoire Hématologie</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Orléans - Laboratoire Hématologie</name>
      <address>
        <city>Orleans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Orléans - Service de Réanimation Médicale</name>
      <address>
        <city>Orleans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thierry Boulain, MD</last_name>
    </contact>
    <investigator>
      <last_name>Thierry Boulain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin - Laboratoire Hématologie</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin - service de Réanimation</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Paul MIRA, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Paul MIRA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers - Service Réanimation</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Pierre FRAT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Pierre FRAT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers - Laboratoire Hématologie</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Rennes - service de Réanimation</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yves LE TULZO, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yves LE TUZO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Rennes - Laboratoire Hématologie</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mikael ROUSSEL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mikael ROUSSEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours - Laboratoire Hématologie</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHU Tours - Service de Réanimation</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuelle MERCIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuelle MERCIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 21, 2013</lastchanged_date>
  <firstreceived_date>November 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>The acute phase of Sepsis</keyword>
  <keyword>multiparameter 8-color flow cytometry</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
